By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sunesis Pharmaceuticals, Inc. 

395 Oyster Point Boulevard
Suite 400
South San Francisco  California  94080  U.S.A.
Phone: 650-266-3500 Fax: 650-266-3501


SEARCH JOBS


Industry
Pharmaceutical

Segment
Biotechnology





Company News
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS At American Society of Hematology Annual Meeting 12/9/2014 10:19:28 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Results From Phase 3 VALOR Trial At American Society of Hematology Annual Meeting 12/8/2014 6:34:41 AM
SSF's Sunesis Pharmaceuticals, Inc. (SNSS) Believes It Can End 40 Year AML Drought Despite "Failed" Phase 3 Study 12/8/2014 6:31:58 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call And Slide Webcast Tuesday, December 9 Following Presentation Of Phase 3 12/5/2014 10:34:55 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Publication Of REVEAL-1 Trial Results In The British Journal Of Haematology 11/24/2014 12:38:30 PM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Publication Of Vosaroxin Phase 1b/2 AML Trial Results In Haematologica 11/19/2014 9:32:58 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Late-Breaking Presentation Of Phase 3 VALOR Trial At American Society of Hematology Annual Meeting 11/17/2014 10:42:13 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Reports Third Quarter 2014 Financial Results And Recent Highlights 11/10/2014 8:12:14 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Present At Upcoming Investor Conferences 11/5/2014 10:12:32 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call On November 10th To Discuss Third Quarter 2014 Financial Results And Recent Highlights 11/3/2014 8:37:43 AM
12345678910...
//-->